Equity (Tables)

6 Months Ended

Jun. 30, 2025

Equity [Abstract]

Summary of the Warrants

	Number of shares		Exercise price		Expiration date
Public Warrants (1)		1,437,447	$	115.00	July 16, 2026
Sponsor Warrants (1)		849,999	$	115.00	July 16, 2026
May 2022 PIPE Warrants		405,405	$	3.50	October 10, 2028
March 2023 PIPE Warrants		208,485	$	30.00	March 27, 2028
March 2023 PIPE Warrants (3)		729,698	$	2.50	June 30, 2030
March 2023 Loan Warrants		75,000	$	1.69	March 17, 2028
April 2023 Registered Direct Warrants		435,625	$	7.50	October 10, 2028
April 2023 Registered Direct Warrants		487,451	$	3.50	October 10, 2028
May 2023 PIPE Warrants (3)		581,394	$	2.50	June 30, 2030
June 2023 Warrants (2)		50,000	$	1.69	June 20, 2028
June 2023 Loan Warrants		300,000	$	8.10	June 20, 2028
July 2023 Registered Direct Warrants		857,142	$	3.50	January 31, 2029
January 2024 Bridge Loan - Tranche #1 Warrants		1,650,000	$	2.49	January 16, 2029
January 2024 Bridge Loan - Tranche #2 Warrants		1,350,000	$	2.99	July 15, 2029
March 2024 RWI Forbearance Warrants		300,000	$	5.90	June 20, 2028
November 2024 Purchaser Warrants		263,156	$	2.85	November 25, 2029 - December 3, 2029
November 2024 Placement Agent Warrants		52,500	$	3.56	November 25, 2029 - December 3, 2029
February 2025 Binding Term Sheet Warrants		100,000	$	1.69	February 11, 2030
Faithstone Strategic Advisory		1,500,000	$	6.67	May 19, 2030
		11,633,302

(1)	The number of Public Warrants and Sponsor Warrants outstanding was not adjusted for the reverse stock split. There are 14,374,478 Public Warrants and 8,499,999 Sponsor Warrants outstanding. After the reverse stock split, the number of warrants outstanding remains the same. However, each outstanding warrant is now exercisable for one-tenth of a share of Class A common stock, and the exercise price per share was adjusted to $115.00 as a result of the split.
(2)	In connection with the execution of the Starr Forbearance Agreement on March 13, 2024, described above under Warrant Modification and further in Note 10, the Company agreed to reprice 75,000 warrants with a previous exercise price of $7.10 and 50,000 warrants with a previous exercise price of $8.10 held by C.V. Starr to a new exercise price of $5.90. The term of the warrants was unchanged.
(3)	In connection with the June 23, 2025, Securities Purchase Agreement described above, the Company agreed to reprice an aggregate 1,311,092 warrants from $10.00 to $2.50 and to extend the expiration from dates in May 2028 to June 30, 2030.